These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14315213)

  • 21. THE ACTION OF ANGIOTENSIN IN MAN.
    DEBONO E; LEEGDE J; MOTTRAM FR; PICKERING GW; BROWN JJ; KEEN H; PEART WS; SANDERSON PH
    Clin Sci; 1963 Aug; 25():123-57. PubMed ID: 14058238
    [No Abstract]   [Full Text] [Related]  

  • 22. [STUDIES ON THE CIRCULATORY EFFECT OF ELEDOISIN IN HUMANS AND EXPERIMENTAL ANIMALS].
    BROGHAMMER H
    Klin Wochenschr; 1963 Nov; 41():1097-104. PubMed ID: 14109873
    [No Abstract]   [Full Text] [Related]  

  • 23. [Hemodynamic, humoral and nervous factors in the genesis of acute pulmonary edema due to adrenalin in the rabbit].
    CAVALCA L; GUARDAMAGNA C; SCHLECHTER P; ZANUSSI C
    G Clin Med; 1956 Mar; 37(3):359-71. PubMed ID: 13365949
    [No Abstract]   [Full Text] [Related]  

  • 24. EFFECTS OF ANGIOTENSIN AND DESOXYCORTICOSTEROL ON ISOLATED ARTERIES AND VEINS.
    SPARKS HV
    Med Bull (Ann Arbor); 1963; 29():243-9. PubMed ID: 14048072
    [No Abstract]   [Full Text] [Related]  

  • 25. THE EFFECTS OF ANGIOTENSIN ON THE CIRCULATION AND MYOCARDIAL METABOLISM OF DOGS WITH EXPERIMENTALLY PRODUCED MYOCARDIAL INFARCTION.
    RIBEILIMA J
    Am Heart J; 1965 May; 69():637-41. PubMed ID: 14280105
    [No Abstract]   [Full Text] [Related]  

  • 26. THE PHARMACOLOGY OF ISOLATED VEINS.
    SUTTER MC
    Br J Pharmacol Chemother; 1965 Jun; 24(3):742-51. PubMed ID: 14340928
    [No Abstract]   [Full Text] [Related]  

  • 27. [ACTION ON THE CIRCULATION OF SOME VASOACTIVE DRUGS WITH HYPERTENSIVE ACTION. MODIFICATIONS OF THE RENAL CIRCULATION].
    DESSY P; USLENGHI E; RUSCHENA A
    Minerva Med; 1965 Jun; 56():2174-7. PubMed ID: 14328099
    [No Abstract]   [Full Text] [Related]  

  • 28. ORIGIN OF BLOOD FIBRINOLYTIC ACTIVITY.
    HOLEMANS R
    Lancet; 1963 Aug; 2(7303):364-5. PubMed ID: 14044283
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental studies on the pulmonary edema investigation with special reference to permeability of the pulmonary capillary from the standpoint of pulmonary lymphatic return.
    Oka K
    Jpn Circ J; 1973 Nov; 37(11):1343-54. PubMed ID: 4801393
    [No Abstract]   [Full Text] [Related]  

  • 30. [Possibility of an extravascular regulation of the lesser circulation: bronchomotor tonus and experimental pulmonary edema. Clinical, physiopathological and anatomopathological study].
    CELLERINO A; BALBO G; ROLFO F
    Arch Sci Med (Torino); 1961 Mar; 111():145-92. PubMed ID: 13691888
    [No Abstract]   [Full Text] [Related]  

  • 31. CONTROL OF RENIN SECRETION.
    SKINNER SL; MCCUBBIN JW; PAGE IH
    Circ Res; 1964 Jul; 15():64-76. PubMed ID: 14196207
    [No Abstract]   [Full Text] [Related]  

  • 32. RENAL VASCULAR RESPONSE TO ANGIOTENSIN AND OTHER VASOACTIVE AGENTS IN ENDOTOXIN SHOCK.
    EMERSON TE; BRAKE CM; HINSHAW LB
    Am J Physiol; 1964 Dec; 207():1260-4. PubMed ID: 14251929
    [No Abstract]   [Full Text] [Related]  

  • 33. LOSS OF THE RENAL VASOCONSTRICTOR ACTIVITY OF ANGIOTENSIN II DURING RENAL ISCHEMIA.
    MCGIFF JC; ITSKOVITZ HD
    J Clin Invest; 1964 Dec; 43(12):2359-67. PubMed ID: 14234832
    [No Abstract]   [Full Text] [Related]  

  • 34. INFLUENCE OF VENOUS RETURN ON INTRAVENTRICULAR PRESSURE. CHANGES INDUCED BY PARTIAL OCCLUSION OF THE PULMONARY ARTERY WITH REFERENCE TO AORTIC CONSTRICTION ON PERFORMANCE OF THE RIGHT VENTRICLE.
    ARAMENDIA P; TAQUINI CM; TAQUINI AC
    Acta Physiol Lat Am; 1963; 13():208-14. PubMed ID: 14125841
    [No Abstract]   [Full Text] [Related]  

  • 35. CIRCULATORY AUTOREGULATION IN THE FULLY ISOLATED KIDNEY AND IN THE HUMORALLY SUPPORTED, ISOLATED KIDNEY.
    WAUGH WH
    Circ Res; 1964 Aug; 15():SUPPL:156-69. PubMed ID: 14206296
    [No Abstract]   [Full Text] [Related]  

  • 36. THE HYPOTENSIVE ACTIVITY OF N(1-(5-NITRO-2-FURYL) ETHYLIDENE)-3-AMINO-2-OXAZOLIDINONE (NF-219).
    EDLIN AI; BUCKLEY JP; KINNARD WJ; ACETO MD
    Arch Int Pharmacodyn Ther; 1964 Jun; 149():434-40. PubMed ID: 14191076
    [No Abstract]   [Full Text] [Related]  

  • 37. [METABOLIC EFFECTS OF SYNTHETIC ANGIOTENSIN II].
    HEIDENREICH O; KOOK Y; BAUMEISTER L; REUS E
    Arch Int Pharmacodyn Ther; 1964 Apr; 148():309-19. PubMed ID: 14181227
    [No Abstract]   [Full Text] [Related]  

  • 38. VASCULAR EFFECTS OF ANGIOTENSIN AND NOREPINEPHRINE IN THE DOG, CAT, AND MONKEY.
    EMERSON TE; HINSHAW LB; BRAKE CM
    Am J Physiol; 1965 Feb; 208():260-4. PubMed ID: 14259957
    [No Abstract]   [Full Text] [Related]  

  • 39. [PHARMACOLOGICAL ANIMAL EXPERIMENTAL FIBRINOLYSIS].
    RAHN B; VON KAULLAK
    Klin Wochenschr; 1965 Feb; 43():163-9. PubMed ID: 14258513
    [No Abstract]   [Full Text] [Related]  

  • 40. SOME CONSEQUENCES OF LONG-TERM MECAMYLAMINE ADMINISTRATION TO EXPERIMENTAL ANIMALS.
    VIDRIO H; GOMEZ J; RODRIGUEZ R; PARDO EG
    J Pharmacol Exp Ther; 1965 Jul; 149():98-105. PubMed ID: 14334298
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.